Biotech companies raise cash as coronavirus updates lift stocks
Eight publicly traded drugmakers, including Moderna, announced plans Monday to raise nearly $3 billion via offerings of new stock and debt.
Eight publicly traded drugmakers, including Moderna, announced plans Monday to raise nearly $3 billion via offerings of new stock and debt.
